United States · FDA National Drug Code directory
Regadenoson
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71288-201_347eb6ed-dadc-4127-be90-24f65150fbff
- Product NDC
- 71288-201
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Regadenoson
- Labeler
- Meitheal Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220411
- Source listing expiry
- 20261231
Source-listed ingredients
- REGADENOSON — .08 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE, PLASTIC in 1 CARTON (71288-201-85) / 5 mL in 1 SYRINGE, PLASTIC · 71288-201-85
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →